About markers in general surgery

Detalhes bibliográficos
Autor(a) principal: Almeida, Carlos Costa
Data de Publicação: 2014
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://revista.spcir.com/index.php/spcir/article/view/318
Resumo: Some considerations are made on markers sensu lato – substances or situations in the organism, related with a certain nosological entity and that can draw attention to it or help to its diagnosis and evaluation – and the importance they must have in general surgery.Frequently their use is restricted to the biological markers, specially related with tumours, but there is much more than that. A relevant example is the ankle/arm pressure index (AAI), that means lower limb ischemia but is also a marker for atherosclerotic disease, of any localization, already symptomatic or not, and, besides that, an independent predictive factor of cardiovascular mortality: the lesser is its value, the bigger is the risk. Its routine measurement in surgical patients with atherosclerotic risk is, therefore, a medical act that can definitely concur in a very important way to take measures that can help the patient to bear our surgical intervention in the best possible security conditions. Another important example is venous thrombosis, either superficial or deep (venous thromboembolism, VTE), as a tumour marker. Any of them can precede the specific manifestations of the oncologic disease. And, at the same time, some cancers constitute a relevant thrombotic factor, VTE being, in these cases, beyond a marker, a factor for worse oncological prognosis, what implies a redoubled care with its prophylaxis, immediately after the diagnosis and not only pre-operatively, and a fortiori when the already identified thrombotic biomarkers in oncological pathology are present. Concerning tumour biomarkers, the most usually used are listed, in groups, according to their nature. Their utilization is useful, but one should not confuse what we would like them to be with what they really are. With exception of some individual characteristics, specially involving the volume of the tumour, prognosis, orientation of treatment and forecast of its result, what tumor biomarkers consistently give us is information on the immediate result of treatment and, during follow-up, the early detection of recurrence or late metastasis. They must be used as reference for future and, therefore, after a tumour is diagnosed, and before any treatment, it is absolutely mandatory to search for and measure the biomarkers with it usually related.Keywords: Marker, Tumour, Cancer, Atherosclerosis, Venous thrombosis, Ankle-arm pressure index, General Surgery
id RCAP_4995c96153e66bdb6906648928474db9
oai_identifier_str oai:revista.spcir.com:article/318
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling About markers in general surgeryDos marcadores em cirurgia geralSome considerations are made on markers sensu lato – substances or situations in the organism, related with a certain nosological entity and that can draw attention to it or help to its diagnosis and evaluation – and the importance they must have in general surgery.Frequently their use is restricted to the biological markers, specially related with tumours, but there is much more than that. A relevant example is the ankle/arm pressure index (AAI), that means lower limb ischemia but is also a marker for atherosclerotic disease, of any localization, already symptomatic or not, and, besides that, an independent predictive factor of cardiovascular mortality: the lesser is its value, the bigger is the risk. Its routine measurement in surgical patients with atherosclerotic risk is, therefore, a medical act that can definitely concur in a very important way to take measures that can help the patient to bear our surgical intervention in the best possible security conditions. Another important example is venous thrombosis, either superficial or deep (venous thromboembolism, VTE), as a tumour marker. Any of them can precede the specific manifestations of the oncologic disease. And, at the same time, some cancers constitute a relevant thrombotic factor, VTE being, in these cases, beyond a marker, a factor for worse oncological prognosis, what implies a redoubled care with its prophylaxis, immediately after the diagnosis and not only pre-operatively, and a fortiori when the already identified thrombotic biomarkers in oncological pathology are present. Concerning tumour biomarkers, the most usually used are listed, in groups, according to their nature. Their utilization is useful, but one should not confuse what we would like them to be with what they really are. With exception of some individual characteristics, specially involving the volume of the tumour, prognosis, orientation of treatment and forecast of its result, what tumor biomarkers consistently give us is information on the immediate result of treatment and, during follow-up, the early detection of recurrence or late metastasis. They must be used as reference for future and, therefore, after a tumour is diagnosed, and before any treatment, it is absolutely mandatory to search for and measure the biomarkers with it usually related.Keywords: Marker, Tumour, Cancer, Atherosclerosis, Venous thrombosis, Ankle-arm pressure index, General SurgeryTecem-se alguma considerações sobre marcadores sensu lato – substâncias ou situações no organismo, relacionadas com uma determinada entidade nosológica e que chamam a atenção para ela ou ajudam ao seu diagnóstico e avaliação – e a importância que devem ter em cirurgia geral. Frequentemente o seu uso é restringido aos marcadores biológicos, sobretudo relacionados com tumores, mas há muito mais do que isso. Um exemplo marcante é o índice de pressão tornozelo/braço (ITB), com o significado de isquémia dos membros inferiores mas também um marcador de doença aterosclerótica, seja onde for a sua localização, já sintomática ou ainda não, e que é, para além disso, um factor preditivo independente de mortalidade cardiovascular: o risco é tanto maior quanto menor for o seu valor. A sua medição de rotina em doentes cirúrgicos com risco aterosclerótico é, pois, um acto médico que pode concorrer de modo muito importante para se tomarem medidas que ajudem o doente a suportar a nossa intervenção cirúrgica nas melhores condições de segurança. Outro exemplo importante é a trombose venosa, seja superficial seja profunda (tromboembolismo venoso, TEV), como marcador tumoral. Qualquer uma delas pode anteceder as manifestações específicas da doença oncológica. Ao mesmo tempo, alguns cancros constituem um factor trombótico relevante, sendo nesses casos o TEV, para além de marcador, um factor de pior prognóstico oncológico, o que implica um cuidado redobrado com a sua profilaxia, logo após o diagnóstico e não apenas pré-operatória e, por maioria de razão, quando presentes os biomarcadores trombóticos já identificados em patologia oncológica. Quanto aos biomarcadores tumorais, os mais vulgarmente utilizados são elencados, por grupos, de acordo com a sua natureza. É útil o seu uso, mas não se deve confundir o que gostaríamos que os biomarcadores fossem com aquilo que realmente são. Ressalvando algumas características individuais, sobretudo no que respeita a volume de tumor, prognóstico, orientação de tratamento e previsão do seu resultado, o que os biomarcadores tumorais consistentemente nos dão é informação sobre o resultado imediato do tratamento e, no follow-up, o conhecimento precoce da ocorrência de recidiva ou de metastização tardia. Devem ser utilizados como referência para o futuro e, por isso, logo após o diagnóstico de um tumor, e antes de qualquer tratamento, é absolutamente mandatório fazer a avaliação quantitativa dos biomarcadores com ele habitualmente relacionados.Palavras-chave: Marcador, Tumor, Cancro, Aterosclerose, Trombose venosa, Índice de pressão tornozelo-braço, Cirurgia GeralSociedade Portuguesa de Cirurgia2014-01-17info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://revista.spcir.com/index.php/spcir/article/view/318Revista Portuguesa de Cirurgia; No 26 (2013): Setembro 2013 - II Série; 31-36Revista Portuguesa de Cirurgia; No 26 (2013): Setembro 2013 - II Série; 31-362183-11651646-6918reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revista.spcir.com/index.php/spcir/article/view/318https://revista.spcir.com/index.php/spcir/article/view/318/309Copyright (c) 2016 Revista Portuguesa de Cirurgiainfo:eu-repo/semantics/openAccessAlmeida, Carlos Costa2024-02-22T22:32:48Zoai:revista.spcir.com:article/318Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:10:54.877437Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv About markers in general surgery
Dos marcadores em cirurgia geral
title About markers in general surgery
spellingShingle About markers in general surgery
Almeida, Carlos Costa
title_short About markers in general surgery
title_full About markers in general surgery
title_fullStr About markers in general surgery
title_full_unstemmed About markers in general surgery
title_sort About markers in general surgery
author Almeida, Carlos Costa
author_facet Almeida, Carlos Costa
author_role author
dc.contributor.author.fl_str_mv Almeida, Carlos Costa
description Some considerations are made on markers sensu lato – substances or situations in the organism, related with a certain nosological entity and that can draw attention to it or help to its diagnosis and evaluation – and the importance they must have in general surgery.Frequently their use is restricted to the biological markers, specially related with tumours, but there is much more than that. A relevant example is the ankle/arm pressure index (AAI), that means lower limb ischemia but is also a marker for atherosclerotic disease, of any localization, already symptomatic or not, and, besides that, an independent predictive factor of cardiovascular mortality: the lesser is its value, the bigger is the risk. Its routine measurement in surgical patients with atherosclerotic risk is, therefore, a medical act that can definitely concur in a very important way to take measures that can help the patient to bear our surgical intervention in the best possible security conditions. Another important example is venous thrombosis, either superficial or deep (venous thromboembolism, VTE), as a tumour marker. Any of them can precede the specific manifestations of the oncologic disease. And, at the same time, some cancers constitute a relevant thrombotic factor, VTE being, in these cases, beyond a marker, a factor for worse oncological prognosis, what implies a redoubled care with its prophylaxis, immediately after the diagnosis and not only pre-operatively, and a fortiori when the already identified thrombotic biomarkers in oncological pathology are present. Concerning tumour biomarkers, the most usually used are listed, in groups, according to their nature. Their utilization is useful, but one should not confuse what we would like them to be with what they really are. With exception of some individual characteristics, specially involving the volume of the tumour, prognosis, orientation of treatment and forecast of its result, what tumor biomarkers consistently give us is information on the immediate result of treatment and, during follow-up, the early detection of recurrence or late metastasis. They must be used as reference for future and, therefore, after a tumour is diagnosed, and before any treatment, it is absolutely mandatory to search for and measure the biomarkers with it usually related.Keywords: Marker, Tumour, Cancer, Atherosclerosis, Venous thrombosis, Ankle-arm pressure index, General Surgery
publishDate 2014
dc.date.none.fl_str_mv 2014-01-17
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revista.spcir.com/index.php/spcir/article/view/318
url https://revista.spcir.com/index.php/spcir/article/view/318
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revista.spcir.com/index.php/spcir/article/view/318
https://revista.spcir.com/index.php/spcir/article/view/318/309
dc.rights.driver.fl_str_mv Copyright (c) 2016 Revista Portuguesa de Cirurgia
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2016 Revista Portuguesa de Cirurgia
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Cirurgia
publisher.none.fl_str_mv Sociedade Portuguesa de Cirurgia
dc.source.none.fl_str_mv Revista Portuguesa de Cirurgia; No 26 (2013): Setembro 2013 - II Série; 31-36
Revista Portuguesa de Cirurgia; No 26 (2013): Setembro 2013 - II Série; 31-36
2183-1165
1646-6918
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137759216009216